Christopher David Ozeroff's Net Worth
-$211 Thousand
Who is Christopher David Ozeroff?
Christopher David Ozeroff does not have any significant net worth to report based on the numbers we have. This is based on reported shares in ARCA biopharma, Inc..
SEC CIK
Christopher David Ozeroff's CIK is 0001454996
Past Insider Trading and Trends
2010 was Christopher David Ozeroff's most active year for acquiring shares with 3 total transactions. Christopher David Ozeroff's most active month to acquire stocks was the month of January. 2016 was Christopher David Ozeroff's most active year for disposing of shares, totalling 3 transactions. Christopher David Ozeroff's most active month to dispose stocks was the month of March. 2021 saw Christopher David Ozeroff paying a total of $113,210.00 for 77,500 shares, this is the most they've acquired in one year. In 2015 Christopher David Ozeroff cashed out on 1,129 shares for a total of $7,135.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARCA biopharma, Inc. (ABIO) Snapshot price: $1.6166
S.V.P., General CounselChristopher David Ozeroff owns 50,970 units of Common Stock which is worth $82,398.10. From 2009 to 2021 Christopher David Ozeroff acquired a total of 250,826 shares in ARCA biopharma, Inc. at a cost of $308,648.86, Christopher also disposed a total of 45,781 shares of ARCA biopharma, Inc. equalling to $15,676.86.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
| +5,154.64% | 50K |
$2.26 | $113,210.00 | 50.97K |
Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
| -2.33% | -418.00 |
$2.41 | -$1,007.38 | 17.52K |
Scheduled
|
Apr 4
| ||
Form 4
| -2.53% | -465.00 |
$2.61 | -$1,213.65 | 17.93K |
Scheduled
|
Feb 27 - Feb 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| -6.05% | -1.19K |
$2.89 | -$3,424.65 | 18.4K |
Scheduled
|
Sep 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| -1.83% | -366.00 |
$3.52 | -$1,288.32 | 19.59K |
Scheduled
|
Apr 5
| ||
Form 4
| -2.24% | -458.00 |
$3.51 | -$1,607.58 | 19.95K |
Scheduled
|
Mar 1
| ||
Form 4
| -5.24% | -1.13K |
$6.32 | -$7,135.28 | 20.41K |
Scheduled
|
Sep 18
| ||
Form 4
| +18.98% | 24.05K |
—
|
—
| 150.79K |
Feb 12
| |||
Form 4
| +36.96% | 34.2K |
$1.95 | $66,690.00 | 126.74K |
Feb 27
| |||
Form 4
| +427.67% | 75K |
$1.38 | $103,500.00 | 92.54K |
Sep 17
| |||
Form 4
| +152.01% | 63.48K |
$0.39 | $25,002.80 | 105.23K |
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +5.16% | 2.05K |
$0.06 | $246.06 | 41.76K |
Jul 2 - Jul 7
| |||
Form 4
| -50.00% | -39.71K |
—
|
—
| 39.71K |
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||